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Background: 1,4-Naphthoquinone analogs, such as plumbagin, are toxic compounds due to their redox cycling and thiol-
reactive properties.
Results: The p300 inhibitor PTK1, a plumbagin derivative with greatly reduced toxicity, was synthesized and characterized.
Conclusion: PTK1 is a reversible, non-competitive inhibitor of p300 KAT activity with reduced toxicity.
Significance: These studies provide insight into naphthoquinone-mediated KAT inhibition and describe the synthesis of a
therapeutically important, non-toxic inhibitor.
Hydroxynaphthoquinone-based inhibitors of the lysine
acetyltransferase KAT3B (p300), such as plumbagin, are rela-
tively toxic. Here, we report that free thiol reactivity and redox
cycling properties greatly contribute to the toxicity of plumba-
gin. A reactive 3rd position in the naphthoquinone derivatives is
essential for thiol reactivity and enhances redox cycling. Using
this clue, we synthesized PTK1, harboring amethyl substitution
at the 3rd position of plumbagin. This molecule loses its thiol
reactivity completely and its redox cycling ability to a lesser
extent. Mechanistically, non-competitive, reversible binding of
the inhibitor to the lysine acetyltransferase (KAT) domain of
p300 is largely responsible for the acetyltransferase inhibition.
Remarkably, the modified inhibitor PTK1 was a nearly non-
toxic inhibitor of p300. The present report elucidates themech-
anism of acetyltransferase activity inhibition by 1,4-naphtho-
quinones, which involves redox cycling and nucleophilic adduct
formation, and it suggests possible routes of synthesis of the
non-toxic inhibitor.
Over the past decade, several small molecule modulators of
chromatin-modifying enzymes have been discovered (1, 2).
These molecules include specific and nonspecific inhibitors of
histone deacetylases, histone acetyltransferases (now known as
lysine acetyltransferases or KATs),3 histone methyltrans-
ferases, and specific activators of the lysine acetyltransferases
3B/3A (p300/CBP). 1,4-Naphthoquinone derivatives are natu-
rally occurring compounds that are present in the Plumbago
and Diospyros plant genera and have a variety of biological
activities (3). Our laboratory previously reported that one of the
1,4-naphthoquinones, plumbagin, is a potent inhibitor of the
KAT p300. Plumbagin specifically inhibits p300-mediated p53
acetylation but not the p53 acetylation by the lysine acetyltrans-
ferase KAT2B (p300/CBP-associated factor) (4). This study
described for the first time that a structural entity (a hydroxyl
group at the 5th position of plumbagin) is required for the inhi-
bition of acetyltransferase activity. However, naphthoquinone
derivatives are relatively toxic molecules, and their efficacy and
utility in vivo has been limited due to this characteristic (5–8).
The aimof the present study is to understand themechanismof
KAT inhibition as well as the chemical entity responsible for its
cytotoxicity and, thus, to synthesize a non-toxic KAT inhibitor.
Among the different small molecule KAT inhibitors known
to date, Lys-CoAwas the first to be discovered as a p300 acetyl-
transferase-specific inhibitor (9). The catalytic mechanisms
of the enzyme have been investigated from the co-crystal struc-
tural analysis of the p300 KAT domain and Lys-CoA (10). Lys-
CoA interacts extensively with the acetyltransferase domain,
particularly in the hydrophobic tunnel. Lys-CoA-mediated
inhibition supports a Theorell-Chance model rather than a
standard ordered binding, ternary complex, or ping-pong
mechanism. Based on the residues that Lys-CoA binds within
the hydrophobic tunnel, a new enzyme-inhibitory scaffold,
C646, has been synthesized by the same group (11). Over the
years, we have discovered a few naturally occurring, small mol-
ecule KAT inhibitors (4, 12–16). Our investigations have
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revealed that there are pockets in the p300 acetyltransferase
KAT domain, other than the hydrophobic tunnel, where these
small molecules may bind and cause enzyme inhibition (4, 17).
These p300 inhibitors, such as garcinol, plumbagin, and the
p300-specific garcinol derivative LTK14, have at least one bind-
ing site within the KAT domain (17). A docking analysis with
plumbagin has shown that bindingmay not occur in the hydro-
phobic tunnel of the KAT domain, suggesting that other bind-
ing pockets might exist (4). Although themechanisms of action
for these small molecule inhibitors have been investigated in
terms of enzyme binding and kinetics, the chemical nature of
these small molecules has received much less attention. Nota-
bly, most KAT inhibitors consist of hydroxyl groups, leading to
speculation that the -OH groups could facilitate enzyme-small
molecule interactions and thereby KAT inhibition (4). In this
respect, we have previously reported that the activity of plum-
bagin can be ascribed to the hydrogen bonding between the
hydroxyl group and Lys-1358 in the KATdomain (4). However,
plumbagin is known to react with free -SH (thiol) groups avail-
able in the intracellular milieu, including glutathione, and is
also involved in redox cycling. These chemical properties of
1,4-naphthoquinones, such as plumbagin, may be the cause of
their cytotoxicity and may influence their KAT-inhibitory
activity. The toxicity also hampers their utility (5–8). There-
fore, we are interested in investigating the role of the chemical
nature of plumbagin and other related 1,4-naphthoquinone
analogs in KAT inhibition and cytotoxicity with the ultimate
goal of synthesizing a non-toxic, reversible inhibitor.
Our results suggest that themajormechanism of plumbagin-
mediated KAT inhibition is through irreversible protein inter-
actions. However, the cytotoxicity of plumbagin analogs is due
to their ability to generate reactive oxygen species as well as
their reactivity to thiols. The structure-function relationships
of these 1,4-naphthaquinones lead us to the conclusion that the
structural moieties responsible for KAT inhibition and those
responsible for toxicity do not overlap and can be delineated.
Based on these observations, we have synthesized a new mole-
cule that does not have free thiol reactivity and has less redox
cycling potential but retains KAT inhibitory activity. Thus, this
molecule could potently reduce histone acetylation in cell-
based assays with greatly decreased toxicity.
EXPERIMENTAL PROCEDURES
Cell Culture, Treatments, and Immunoblotting—SHSY-5Y
(human neuroblastoma) and HEK293 (human embryonic kid-
ney) cells were cultured inDulbecco’smodified Eagle’smedium
(DMEM) with 10% fetal bovine serum (FBS) at 37 °C and 5%
CO2 in an incubator. HeLa S3 cells were cultured in F-12K
(Invitrogen) medium supplemented with 10% FBS. Cells (3 
106 cells/60-mm dish) were seeded and then treated 12 h later
with plumbagin and other compounds at the desired concen-
trations for 6 h. In the case of N-acetyl cysteine (NAC) treat-
ment, the cells were pretreated with 2 mMNAC for 2 h prior to
the addition of plumbagin. After collecting cells at the indicated
time points, cell lysates were prepared using Laemmli sample
buffer (60mMTris-Cl, pH 6.8, 2% SDS, 10% glycerol, 5%-mer-
captoethanol, and 0.01% bromphenol blue). The proteins were
separated on acrylamide gels, and immunoblotting analysis was
performed. Briefly, the proteins were resolved on 12% SDS-
polyacrylamide gels and transferred to nitrocellulose mem-
branes using a semidry transfer apparatus (Bio-Rad). Mem-
branes containing the transferred proteins were blocked using
5% skim milk solution. The membranes were probed using
polyclonal antibodies against histone H3K9 acetylation
(Abcam, ab16635), H2AX (Abcam, 11174), and H3 (labora-
tory reagent) for 3 h at 4 °C. These membranes were incubated
with a horseradish peroxidase-conjugated anti-IgG antibody
(Bangalore Genei). After the addition of an HRP substrate
(PICO West, Thermo Scientific) to the membrane, lumines-
cent bands were captured using x-ray films.
Cell Viability Assay—For quantitation of cell viability, we
performed a 3-(4,5-dimethylthiozol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT) assay. SHSY-5Y cells were seeded in
96-well plates (5000 cells/well). After 12 h, naphthoquinone
derivatives were resuspended in the culturemedium and added
to the wells at the desired concentrations. After 24 h, the com-
pound-containingmediumwas removed, and equal volumes of
freshmediumwere added to eachwell alongwith 20l ofMTT
(Sigma; 5 mg/ml in PBS). As expected, MTT was reduced to
purple-colored formazan only in viable cells. After incubation
for 4 h, DMEM was removed by syringe, and the formazan
crystals were redissolved in 200 l of DMSO. The plate was
incubated at 37 °C for 5 min. The color was quantified with an
ELISA plate reader (Versa Max ELISA plate reader, Molecular
Devices, 595-nm wavelength).
Detection and Measurement of ROS—HEK293 and HeLa
cells were grown in their respective media to 75% confluence.
For fluorescence-based images, cells were grown on coverslips
coated with poly-L-lysine. Cells were washed with PBS and
treated with 5 M CM-H2DCFDA (Invitrogen) for 20 min at
37 °C under 5% CO2. The cells were then treated with different
concentrations of compounds for the indicated times. Later,
the cells were trypsinized and resuspended in PBS, and the
fluorescence intensity was measured by flow cytometry. The
sample was excited at 485 nm, and fluorescence was measured
at 530 nm. For imaging, coverslips containing cells werewashed
with PBS and were mounted onto a glass slide using 70% glyc-
erol as a mountant. Images were captured using a Zeiss Axios-
kop 2 Plus fluorescence microscope.
Lysine Acetyltransferase Assay (Filter-binding Assay)—Ly-
sine acetyltransferase assays were performed as described pre-
viously (9). In brief, 800 ng of highly purifiedHeLa core histones
was incubated in HAT assay buffer at 30 °C for 10 min with
baculovirus-expressed recombinant p300 or CBP in the pres-
ence or absence of select compounds. This procedure was fol-
lowed by the addition of 1.0 l of 3.6 Ci/mM [3H]acetyl-CoA
(PerkinElmer Life Sciences). This mixture was further incu-
bated for 10min. The reactionmixture was then kept on ice for
5 min to stop the reaction, spotted onto P81 (Whatman) filter
paper, and dried. Scintillation counts were recorded on a Wal-
lac 1409 liquid scintillation counter. All assays were performed
in replicates, and the average was plotted, with error bars indi-
cating the S.D.
DTNBAssay andUV-visibleAbsorption/Emission Spectrometry—
DTNB solution (3 mg/ml) was prepared in potassium phos-
phate buffer (100 mM, pH 6.8). NAC, DTT, and 1,4-naphtho-
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quinone derivatives were dissolved in 100 mMDMSO. Initially,
increasing concentrations of NAC and DTT (25–150 M) were
added to 100 l of phosphate buffer. 1,4-Naphthoquinone
derivatives were subsequently added tomake a final concentra-
tion of 50M.An incubation time of 5min at room temperature
was followed by the addition of 100l of DTNB solution,main-
taining the total reaction volume as 200 l in all cases. The
reactionwas allowed to proceed for 5min at room temperature,
and the absorbance of the solution was analyzed at 412 nm
using a VersaMax ELISA plate reader (Molecular Devices). For
performing UV-visible absorption spectrometry, 1,4-naphtho-
quinone derivatives (1 mM in DMSO) were diluted in 1 ml of
100mMpotassiumphosphate buffer (pH6.8) or 100mMHEPES
buffer (pH 7.5) and were scanned for UV-visible absorption
from 200 to 600 nM. Subsequently, NAC (1 mM in DMSO) was
added, wherever necessary, to the buffer containing the deriv-
atives, and scanning was repeated. The absorption spectrum
was read using a spectrophotometer (U-2010, Hitachi). The
same sets of solutions were also used for measuring the excita-
tion wavelength and emission spectra using FluoroMax-3
(Horiba Jobin Yvon).
Kinetic Characterization—Lysine acetyltransferase assays
were carried out with an ectopically expressed baculoviral con-
struct encoding full-length p300, in the absence or presence of
different concentrations of the inhibitor PTK1 (0, 15, 20, 25, 35,
and 45 M). The enzyme is known to catalyze a bisubstrate
reaction comprising two substrates, namely core histone and
[3H]acetyl-CoA.Therefore, a kinetic analysis was performed on
two different combinations. The enzyme activity was deter-
mined at increasing concentrations (1–8 M) of [3H]acetyl-
CoAwhile keeping the concentration of core histones constant
at 1.7 M. In the second combination, the [3H]acetyl-CoA con-
centration was kept constant at 1.6 M while the core histone
concentrationswere varied from5 to 70nM.The reaction veloc-
ity was determined as a function of the incorporation of radio-
activity and was expressed as counts/min (cpm). All of the
experiments were conducted in triplicate, and the values were
within 15% of the error range. The Michaelis-Menten plot was
generated using the model, y Vmax [S]/(Km [S]). The Ki
was determined by fitting to a straight line by the least square
method in a Lineweaver-Burk plot using GraphPad prism ver-
sion 5.0 software.
Reversibility Studies—The reversibility of the inhibitors was
established by the time-dependent dilution and “drop dialysis”
methods. For dialysis, the enzyme p300 was incubated with
inhibitors for 30 min, and the mixture was dialyzed at 4 °C
against 2HAT assay buffer using 0.05-mMillipore “V series
membrane” to remove the inhibitors. The residual activity was
assayed and compared with the predialysis activity. For time-
dependent dilution-based experiments, full-length p300 was
preincubated in 1 HAT assay buffer at pH 8.0 with either
enzyme alone or with increasing concentrations (25–100 M)
of inhibitors with varying preincubation times (1–15 min). Ali-
quots of an appropriate volume were taken from each reaction
mixture to make it final 1:25 dilution in every case. From each
reaction mixture, the residual activity was measured as a per-
centage of the control and plotted against the preincubation
time. Semilogarithmic plots were constructed, and the data
were fit using the semilog line module of GraphPad prism ver-
sion 5.0. The rate of inactivation was measured by fitting to the
equation, y y intercept slope log(x), where x is logarith-
mic, y is linear, and the rate is equivalent to the slope equal to
the apparent inactivation constant (kobs per min) at each inhib-
itor concentration.
Dynamic Light Scattering—The measurements were per-
formed on a Zetasizer Nano S particle analyzer (Malvern
Instruments) with a helium-neon laser (632.8 nm) light source
that utilizes 4-milliwatt power at the same wavelength. Scat-
tered light from the samples was collected at an angle of 173°.
The built-in software generates a correlation curve from the
intensity autocorrelation function. The intensity-weighted
mean hydrodynamic diameter, or Zav diameter, of the sample
was obtained from the cumulants analysis of the correlation
curve. To study the effect of plumbagin, PTK1, and juglone on
p300 oligomerization and compare their adduct-forming abili-
ties, 5M p300 in 10mMTris-HCl at pH 7.5 containing 150mM
NaCl was treated with increasing concentrations (25–100 M)
of the three compounds, and the Zav diameters of treated and
untreated p300 were monitored by dynamic light scattering.
Ten measurements (10 runs for each measurement) were
recorded for each sample at 25 °C. Because the compounds are
dissolved in DMSO, in control experiments, p300 was treated
with an equal volume of DMSO without the compound(s), and
the hydrodynamic parameters mentioned above were checked
to confirm the absence of any alteration.
Surface-enhanced Raman Spectroscopy (SERS) Analysis—
SERS spectra were recorded in a Raman system using 180°
back-scattering geometry and a 632.8-nm helium-neon laser
(model 30995, Research Electro Optics, Inc.) as a Raman exci-
tation source (18, 19). The spectrometer consists of a mono-
chromator (HORIBA JOBIN YVON, iHR 320) and a Peltier-
cooled CCD (Andor iDus). A holographic 1800 grooves mm1
grating was used along with the 200-mspectrograph entrance
slit setting, providing3 cm1 resolution. For SERS studies of
protein, a 60 infinity-corrected objective (Nikon Plan Apo;
numerical aperture 0.9) was used. The laser power used at the
sample was 5milliwatts. Samples were prepared by concentrat-
ing the silver nanoparticles to 10 times, and a concentrated
nanoparticle solution/analyte ratio of 4:1 was maintained. The
typical accumulation time of 30 s was used. The SERS spectrum
was smoothened using a standard five-point fast Fourier trans-
form filtering technique, as shown in Fig. 9D. The silver solu-
tionwas prepared as reported previously (20). Initially, 45mg of
AgNO3 was dissolved in 250 ml of water, and the solution was
brought to a boil. A solution of 1% sodium citrate (5 ml) was
then added to the AgNO3 solution under vigorous stirring, and
boiling was continued for 60 min. The plasmon absorption
maximum was located at 420 nm.
Docking Studies—The crystal structure of p300 KAT domain
was extracted from the Protein Data Bank using the code 3BIY.
The structure of the inhibitor PTK1 was optimized using the
GAUSSIAN 03 program (21). Docking analysis was performed
with Autodock version 4.2 using a Lamarckian genetic algo-
rithm. A 5-grid spacing of 0.375 was used, and docking was
performed with a flexible ligand with 100 Genetic Algorithm
runs, a population size of 300, 25 105 evaluations, and amax-
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imum of 27,000 generations (22). The analysis of conforma-
tions was conducted based on clusters generated using MGL
Autodock tools version 1.5.4. Figures were created using the
PyMOL molecular graphics system (23).
Synthesis of 5-Hydroxy-2,3-dimethylnaphthalene-1,4-dione
(PTK1)—PTK1 was synthesized as reported elsewhere (24).
Plumbagin was isolated in our laboratory from Plumbago rosea
as reported previously (4). PTK1 was synthesized by mixing
plumbagin (1 mM), acetic acid (12 mM) as a radical source, and
benzene (80 ml) as the solvent. The reaction mixture was
cooled over dry ice and methanol until the solvent was frozen.
The flask was degassed in vacuo for 15 min and filled with
nitrogen. This degassing process was repeated three times.
After adding lead tetra-acetate (3 mM), the flask was placed in
an oil bath, and the mixture was refluxed under a nitrogen
atmosphere for 24 h. Upon completion, the reaction was
quenched with water to decompose the excess lead tetra-ace-
tate. The organic layer was dried over anhydrous Na2SO4 and
evaporated. The obtained crude product was purified by col-
umn chromatography using hexane/ethyl acetate (8.5:1.5).
1H NMR and HRMS characterization of PTK1 were per-
formed as described previously (15). The chemical structure
was confirmed by following parameters: Orange Needles, yield
59%, 1H NMR (400 MHz, CDCl3)  2.17 (s, 6H, 2 CH3), 7.52–
7.64 (m, 3H,Ar-3H), 12.16 (s, 1H,OH).HRMS (m/z): calculated
for C12H10O3, 203.0663; found 203.0681.
Chemicals and Instruments—All of the chemicals were pur-
chased fromSigma-Aldrich.Mass spectrometrywas performed
with a high resolution mass spectrometer (Agilent Technolo-
gies), and NMR spectra were obtained from a Bruker (400-
MHz) NMR spectrometer.
RESULTS
N-Acetyl Cysteine Blocks Plumbagin-mediated KAT Inhibi-
tion as Well as Its Pleiotropic Effects in Vivo—Plumbagin is a
known redox-cycling and free thiol-reactive molecule (25–27).
Both of these properties influence its KAT-inhibitory proper-
ties in cells. Because there are earlier reports that are contradic-
tory with respect to the role of ROS in histone acetylation (28–
30), we investigated the potential effect of ROS generation in
KAT-inhibitory activity and cytotoxicity. To do this, we treated
themammalian cell lines SH-SY5Y, HEK293, andHeLa S3with
plumbagin in the presence of the free radical scavenger NAC.
As observed from the images of cells photographed after 6 h of
treatment, NAC completely negated plumbagin-induced cell
stress (Fig. 1A). Plumbagin induced DNA damage, presumably,
FIGURE 1. N-Acetyl cysteine blocks plumbagin-mediated inhibition of histone acetylation and DNA damage in multiple mammalian cell lines. A,
images of SH-SY5Y, HEK293, and HeLa S3 cells, 6 h after treatment with DMSO, plumbagin, and plumbagin in the presence of NAC. B, immunoblotting (IB)
analysis of H2AX phosphorylation (H2AX) after plumbagin (Plu) treatment in the presence or absence of NAC. C, immunoblotting analysis of histone H3K9
acetylation after plumbagin treatment in the presence or absence of NAC in the indicated cell lines; DMSOwas used as solvent control, and immunoblotting
with H3 antibodies was considered as loading control in B and C. D, immunoblotting analysis of histone H3K9 acetylation after isogarcinol (IsoGar) treatment
in the presence or absence of NAC in the SH-SY5Y cell line; DMSO was used as solvent control, and immunoblotting with H3 antibodies was considered as
loading control.
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due to the generation of ROS. DNA damage is marked by the
predominance of histone H2AX phosphorylation (H2AX).
We observed that 20 M plumbagin drastically induced the
level of H2AX (Fig. 1B, lane 6). Consistent with the absence of
any visible cellular stress, pretreatment for 2 h with 2 mMNAC
almost completely inhibited the plumbagin-induced DNA
damage, as revealed by the near absence of H2AX even at an
80 M concentration in SH-SY5Y and HeLa S3 cells (Fig. 1B,
lanes 3–5). Remarkably, the KAT-inhibitory potential of plum-
bagin was completely abrogated in the presence of NAC (Fig.
1C, lane 5 versus lanes 3 and 4). However, the KAT-inhibitory
activity of another broad spectrum KAT inhibitor, isogarcinol,
remained unaffected in the presence of NAC (Fig. 1D). These
observations imply two possible scenarios: 1) ROS induction
leads to the inhibition of acetylation, and therefore NAC,
through its free radical scavenging property, which could nul-
lify ROS-mediated hypoacetylation, and 2) plumbagin reacts
with free thiols inNAC,which abrogates KAT inhibition. How-
ever, the role of NAC as a free radical scavenger could not be
ruled out from the experiments described above. We therefore
performed the filter binding KAT assays in vitro. In this cell-
free assay, plumbagin cannot generate H2O2 or superoxides.
We observed that p300 and CBP inhibition by plumbagin are
abrogated by NAC (Fig. 2, A and B, lane 5 versus lane 7). It was
also observed that free thiol-containing reducing agents, such as
DTT, have the same ability to abrogate both p300 and CBP KAT
inhibition mediated by plumbagin (Fig. 2, A and B, lane 5 versus
lane6).However, non-thiol reducing agents, such asTrolox, did
not affect plumbagin’s KAT-inhibitory activity (Fig. 2, A and B,
lane 5 versus lane 8). None of these reducing agents prevented
isogarcinol from inhibiting KAT (Fig. 2, A and B, lane 9 versus
lanes 10–12), suggesting that this phenomenon is unique to
plumbagin. Therefore, thiol reactivity is critical in inducing
toxicity and possibly contributed to KAT inhibition in cells.
Free Thiol Reactivity of Plumbagin Influences p300 Inhibition—
Presumably, NAC reactedwith plumbagin through its 3rd posi-
tion. In addition, a reactive 3rd position may cause plumbagin-
mediated toxicity due to enhanced redox cycling and free thiol
reactivity. However, thiol reactivity of themolecule could influ-
ence the inhibition of acetyltransferase activity. We addressed
this possibility through structure-activity relationship analysis.
A variety of analogs of 1,4-naphthoquinone (Fig. 3A) were pro-
cured, and in vitro enzyme assays were performed with these
compounds in the presence or absence of NAC (Fig. 4A). These
small molecules vary substantially in their reactive potential at
the 3rd position. It was observed that all of the analogs with a
chemically reactive 3rd position (1,4-naphthoquinone, mena-
dione, and 5-hydroxy-1,4-naphthalenedione (juglone) but not
lawsone) inhibited p300 activity, albeit to varying extents. Law-
sone did not show significant inhibition even at 100 M.
Although the inhibitory activities of thiol-reactive molecules
such as 1,4-naphthoquinone were abrogated upon the addition
of NAC (similar to the abrogation of plumbagin activity), this
was not the case for juglone. Lawsone could not inhibit p300
significantly, and there was no further change after the addition
ofNAC (Fig. 4A). Considering that the hydroxyl group of plum-
bagin is crucial for p300 inhibition, it was interesting to note
that other analogs without hydroxyl groups, such as 1,4-naph-
thoquinone, also inhibited p300.However 1,4-naphthoquinone
possesses a reactive 3rd position that would enable reactivity to
thiols. Thus, we presumed that the free thiol reactivity of these
analogs with cysteines could influence their inhibitory activity.
To correlate KAT inhibition and free thiol reactivity, we carried
out a colorimetric assay for free thiol estimation using DTNB.
FIGURE 2. NAC blocks plumbagin-mediated KAT inhibition in vitro. Shown is the filter binding acetyltransferase assay using full-length baculovirus-
expressed KATs, p300 (A), CBP (B), and HeLa core histones, with 100 M plumbagin (lanes 5–7 in A and B) or isogarcinol (lanes 9–11 in A and B), either in the
presence or absence of free-thiol-containingNAC andDTT. Filter-binding acetyltransferase assayswere also performedwith plumbagin and isogarcinol in the
absence (lanes 5 and 9, respectively; A and B) or presence of the non-thiol reducing agent Trolox (lanes 8 and 12; A and B). Error bars, S.D.
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The assay is based on the fact that the aromatic disulfide
(DTNB) reacts with aliphatic thiol groups to form a mixed
disulfide and 2-nitro-5-thiobenzoate. DTNB has negligible
absorbance, but when it reacts with -SH groups under mild
alkaline conditions (pH7–8, physiological buffers), the 2-nitro-
5-thiobenzoate anion (TNB2) gives an intense yellow color at
412 nm. Thus, if NAC covalently bound to any of the analogs of
1,4-naphthoquinone derivatives, the abundance of the free
thiol group would be reduced, which would be reflected as a
decrease in the absorbance. The NAC-mediated increase in
absorbance was reduced by 1,4-naphthoquinone, plumbagin,
and menadione at 50 M, in all lanes containing NAC (Fig. 4B).
An electron-donating group (hydroxyl group) occurs at the 5th
position of plumbagin and is conjugated with the carbonyl
group at the 4th position, which results in a diminished-elec-
tron cloud around the C2C3 double bond. This configuration
leads to preferential nucleophilic attack at the 3rd position, and
the structure is subsequently stabilized by the methyl group
present at the 2nd position. In the absence of the electron-
donating group (i.e. the methyl group), the symmetry would
result in nucleophilic attack at either the 2nd or the 3rd posi-
tion, as in the case of 1,4-naphthoquinone.However, in the case
of menadione, which does not possess the hydroxyl group, the
preferential position of nucleophilic attack is at the 3rd position
because the 2nd position is occupied by a methyl group. The
absence of a hydroxyl group at the 5th position coupled with a
single site for nucleophilic addition is probably the reason that
menadione is a weaker inhibitor than 1,4-naphthoquinone or
plumbagin (Fig. 4A). In the case of juglone, the preferential
mode of nucleophilic attack is at the 3rd position. However, the
intermediate thus obtained is not as stable as that of plumbagin,
and hence it results in poor affinity toward a nucleophilic
attack, which can be correlated with a lack of a decrease in
absorbance (Fig. 4B). In the case of lawsone, the 3rd position is
highly nucleophilic in nature, which results in a decrease prob-
ability of NAC reacting with lawsone (Fig. 3B). Reactivity of
1,4-naphthoquinones to the free thiol group was also investi-
gated using DTT, a different source of free thiol (Fig. 4C).
Absorbance at 412 nm increased with increasing concentration
of DTT. However, the increase was absent when 1,4-naphtho-
quinone, plumbagin, and menadione were present in the mix-
ture at 50 M. Consistent with previous observations, deriva-
tives, such as lawsone and juglone, that do not react with NAC
also do not alter the absorbance mediated by DTT. Lawsone
and juglone did not react toDTT,whereas 1,4-naphthoquinone
turned out to be the most reactive in terms of free thiol reactiv-
ity, followed by plumbagin and menadione (Fig. 4C). Because
redox cycling could also influence the DTNB assay, direct reac-
tivity of NAC with various derivatives of 1,4-naphthoquinone
was confirmed by the UV-visible absorption spectra of these
FIGURE 3. Structures of 1,4-naphthoquinone analogs and reactive thiols. A, structures of 1,4-naphthoquinone analogs (I), NAC (II), and DTT (III). The OH
group at the 5th position in the case of plumbagin and juglone is very essential for the inhibition of p300 (see table). B, mechanism of NAC reactivity toward
various analogs of 1,4-naphthoquinone. 1,4-Naphthoquinone analogs can reactwith thiol compounds likeNAC/DTTdue to thepresence of a free electrophilic
3rd position in their generic structure. NAC is unable to react with lawsone due to keto-enol tautomerism.
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compounds in the absence and presence of NAC (Fig. 5, A–C,
left panels). The absorption spectra of plumbagin at 100 M
concentration showed an intense absorbance band at 271 and
420 nm. Upon the addition of NAC, the absorption spectrum
showed a hypochromic shift to 246 and 426 nm. In the case of
1,4-naphthoquinone, two absorption bands were observed at
251 and 347 nm. The addition of NAC shifted the absorption
bands toward a higher wavelength (i.e. 266 and 451 nm). Simi-
larly, in the case of menadione, the UV-visible spectrum
showed three bands at 251, 265, and 345 nm, which upon the
addition of NAC again shifted toward higher wavelengths of
260, 341, and 438 nm, respectively. These results indicated that
the-electron cloud is disturbed around the compounds due to
the addition of NAC, which may be a result of NAC reacting
directly with these molecules. The result of NAC reacting with
the various derivatives of plumbaginwas further reflected in the
changes in the fluorescence emission spectra of thesemolecules
(Fig. 5, A–C, right panels). Plumbagin exhibited an emission
band at449 nm. The intensity of the emission spectra showed
a drastic increase in intensity upon the addition of NAC. A
highly intense emission band was also observed at 505 nm. In
the case of 1,4-naphthoquinone, an intense emission band was
observed at 438 nm, which disappears completely upon the
addition of NAC. Similarly, in the case of menadione, the emis-
sion band at 435 nm disappeared completely upon the addition
ofNAC.These results clearly indicate that the direct reaction of
NAC with 1,4-naphthoquinone derivatives results in a drastic
change in the electronic environment around the molecules,
thereby altering their emission and absorption spectra. These
results, in addition to those obtained with the DTNB assay,
clearly indicate that NAC reacts with these molecules through
its free thiol at the 3rd position of the molecules. Additionally,
these molecules, except juglone, react with NAC and thereby
inhibit KAT activity.
PTK1, a Plumbagin Analog, Inhibits KAT Activity Indepen-
dently of Free Thiol Reactivity—Based on earlier observations, we
hypothesized that, if the reactivity at the 3rd position could be
nullified while maintaining the hydroxyl group at the 5th posi-
tion, then it could be possible to synthesize a non-toxic KAT
inhibitor. Thus, we synthesized PTK1, with a methyl substitu-
tion at the 3rd position of plumbagin (Fig. 6A). Remarkably, it
was observed that the ability of PTK1 to inhibit KATwas insen-
sitive to the presence of NAC in vitro (Fig. 6B). As expected, in
the DTNB-based assay for free thiol, the presence of PTK1 did
not significantly affect free thiol abundance in the reaction con-
taining NAC (Fig. 6C). Fluorescence emission as well as the
UV-visible absorption spectrum of PTK1 were analyzed to
investigate any covalent interaction with free thiol (Fig. 6D).
Unlike other analogs, the PTK1 absorption band at 249 nmwas
not affected at all upon the addition of NAC. PTK1 showed no
FIGURE 4. Free thiol reactivity correlateswithKAT-inhibitoryproperties of plumbagin analogs.A, filter-binding acetyltransferase assays using full-length
baculovirus-expressed p300 and HeLa core histones with 1,4-naphthoquinone, juglone, menadione, plumbagin, and lawsone (100 M each) in the presence
or absence of N-acetyl cysteine (2 mM). B, DTNB assay to assess the abundance of free thiols in different concentrations of NAC, after the addition of
1,4-naphthoquinone, juglone, menadione, plumbagin, and lawsone. C, DTNB assay to assess the abundance of free thiols in DTT after the addition of
1,4-naphthoquinone, juglone, menadione, plumbagin, and lawsone. Error bars, S.D.
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fluorescence emission spectra, and consequently, the changes
with NAC addition could not be monitored. Moreover, this
derivative exhibited the same in vitro KAT inhibition potency
as the parent compound plumbagin (data not shown). To ascer-
tain the inhibition of histone acetylation in cells, we performed
immunoblotting with lysates of SH-SY5Y, HEK293, and HeLa
S3 cells treated with PTK1 at different concentrations using an
H3K9 acetylation antibody. We observed a dose-dependent
decrease in acetylation after 24 h of treatment (Fig. 6E, lane 1
versus lanes 2–5). Collectively, these results suggest that PTK1
is a KAT inhibitor whose activity is independent of free thiol
reactivity.
PTK1 Is a Non-competitive and Reversible Inhibitor of p300—
The kinetic analysis of the PTK1-mediated inhibition of full-
length p300 acetyltransferase revealed a noncompetitive pat-
tern with both of its substrates (i.e. core histones and [3H]ace-
tyl-CoA) (Fig. 7,A and B). The Lineweaver-Burk plots (Fig. 7,A
and B, left panels) at a fixed substrate concentration revealed
that apparent Km values (1.47  0.2 M for acetyl-CoA and
33.33  2 nM for core histone) remained constant while the
Vmax of the enzyme decreased with increasing concentration of
PTK1 (from 8476  268.2 cpm without inhibitors to 3184 
125.6 cpm with 45 M PTK1 for acetyl-CoA and from 4732 
36.52 cpm without inhibitors to 2077 27.16 cpm with 45 M
PTK1 for core histone).We also observed a significant increase
in both the slope (Km/Vmax) and the y intercept (when x 0.0)
by the same factor (2.7-fold for acetyl-CoA and 2.5-fold for core
histone), which distinguishes between inhibition by classical
noncompetitive kinetics and mixed kinetics. The slopes (Km/
Vmax) obtained were further plotted against inhibitor concen-
trations to determine the Ki (inhibitor constant) value. The Ki
of PTK1was determined to be 23M for acetyl-CoA (R2	 0.98;
p
 0.0001) and 30 M for core histone (R2	 0.98; p 0.0002)
(Fig. 7, A and B,middle panels). To further validate the steady-
state kinetics data, they were also analyzed by a secondary plot
(Fig. 7, A and B, right panels), where 1/apparent maximum
velocities (1/Vapp) from Lineweaver-Burk plot were plotted
against the PTK1 concentrations, and the Ki values were found
to be 23 and 30 M for acetyl-CoA and core histones, respec-
tively. The identical Ki and Ki values clearly suggest a purely
non-competitive mechanism of inhibition. Additionally, the
values are comparable with the inhibition constant of plumba-
gin (20–25 M) (4) and strengthen the hypothesis that PTK1
possesses the same inhibition potency in vitro as the parent
plumbaginmolecule. These findings are not surprising, consid-
ering that PTK1 is a methylated derivative of plumbagin, and
the parentmolecule inhibits full-length p300 aswell as themin-
imal KAT domain by a noncompetitive mechanism (4). Bisub-
strate enzymes, such as p300, follow an ordered substrate bind-
ing mechanism (31). The non-competitive inhibitor PTK1
could bind to the free enzyme as well as to the substrate-bound
form, resulting in an abortive ternary complex. The possibility
of a conformational change due to allosteric binding also can-
not be ruled out. In addition, PTK1 may have multiple or par-
tially overlapping binding sites in the biologically relevant full-
length p300.
To investigate and compare the reversibility of the plumba-
gin and PTK1-mediated inhibition, we performed dialysis in
FIGURE 5. NAC reactivity influences the absorption and emission spectrum of 1,4-naphthoquinone analogs. A, UV-visible absorption spectra of plum-
bagin in the presence or absence of NAC (left) and fluorescence emission spectra of plumbagin in the presence or absence of NAC (right). B, UV-visible
absorption spectra of 1,4-naphthoquinone in the presence or absence of NAC (left) and fluorescence emission spectra of 1,4-naphthoquinone in the presence
or absence of NAC (right). C, UV-visible absorption spectra of menadione in the presence or absence of NAC (left) and fluorescence emission spectra of
menadione in the presence or absence of NAC (right). In all cases, the concentrations of the inhibitors and reducing agent used are indicated.
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addition to dilution-based time course inhibition assays (Fig. 8).
In these assays, an indication of reversibility is the indepen-
dence of inhibition with respect to time. Perfectly reversible
inhibitors reach rapid equilibrium with the enzyme, and inhi-
bition does not depend on time. Plumbagin exhibited perfect
time-dependent inhibition at a range of concentrations (25–
100 M) with 1–15 min of preincubation. Inhibition markedly
increased with the time of incubation with the inhibitor. The
inactivation rate constant (kobs) value was determined from the
fitted slope of the plots; for plumbagin, it was 4  102/min
(Fig. 8A, left). This type of inhibition is usually the result of the
irreversible binding of the inhibitor with the enzyme, poten-
tially due to the formation of covalent adducts. In the case of
plumbagin, it could be due to the complex-forming ability
of selective thiol residues in the protein. The irreversibility of
plumbagin-mediated inhibition was further confirmed by the
rapid “drop dialysis” method, in which dialysis of plumbagin
was ineffective in restoring the native activity of the enzyme
(Fig. 8B). This scenario changed when PTK1 was used; we
observed minimal time-dependent decrease when compared
with the without inhibitor control (kobs 9 103/min) (Fig.
8A, right). Moreover, the inhibition of PTK1 was completely
reversible because complete activity could be recovered after
determining the residual activity of the dialyzed enzyme, which
was free fromPTK1 (Fig. 8B). These data suggest that themech-
anism of inhibition of p300 by plumbagin is irreversible,
whereas for PTK1, it is predominantly reversible. Importantly,
when these assays were conducted with theminimal p300 KAT
domain (Fig. 8C), both small molecules behaved in a totally
reversible fashion with no time dependence and completely
regained their activity upon dilution (Fig. 8D). This result also
suggested that the susceptibility to redox cycling and free thiol
reactivity resides in residues outside the KAT domain, presum-
ably in the cysteine- and histidine-rich domains of the full-
length enzyme.
The Binding Sites for Plumbagin and PTK1 Are Probably the
Same within the KAT Domain—It was previously found that
plumbagin could bind to only one site within the KAT domain
of p300, namely, the Lys-1358 residue, by isothermal titration
calorimetry, molecular docking, and mutation studies (4). A
detailed kinetic analysis also revealed a non-competitive mech-
anism of inhibition of both the full-length protein and the KAT
domain. To assess whether the binding site for PTK1 was sim-
ilar to that of plumbagin, we performed molecular docking
using Autodock software (Fig. 9A). The docking study with
PTK1 and the p300 KAT domain showed hydrogen bond for-
mation with residue Lys-1358 (Fig. 9B). The residues involved
in the interaction were Lys-1358, Arg-1356, Thr-1296, Leu-
1298, Glu-1380, Asp-1614, and Asp-1616 (Fig. 9C). This dock-
ing model is consistent with the aforementioned report (4) in
FIGURE 6. PTK1 inhibits p300 independently of free thiol reactivity. A, synthesis of PTK1 from plumbagin. B, filter binding acetyltransferase assays using
full-lengthbaculovirus expressedp300andHeLa corehistoneswithdifferent concentrationsof PTK1 in the absenceandpresenceofNAC.C, in vitroDTNBassay
to assess the abundance of free thiol in the presence or absence of PTK1. D, UV-visible absorption spectrum of PTK1 in the in presence or absence of NAC. E,
immunoblotting analysis (IB) of cell lysates upon 24 h of treatment by PTK1 using H3K9 acetylation antibodies. The concentrations of PTK1 used are indicated
in the figure. Error bars, S.D.
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which it was shown that the -OH group of plumbagin, which
has a structure similar to that of PTK1 (without the methyl
group at C3), is important because plumbagin forms a hydro-
gen bond with Lys-1358 through this group. It had also been
shown that alkyl substitution at the -OH position could not
inhibit KAT activity. Additionally, Lys-1358 was found to be
absolutely critical for KAT activity. A hydrogen bond is formed
with the Arg-1356 residue, and, along with the hydrogen bond
formed with Lys-1358, it could facilitate interactions with the
other four residues. The docking of PTK1 with the p300 KAT
domain suggested that hydrogen bonding through the -OH
group of the molecule to the Lys-1358 residue could result in
the inhibition of KAT activity. Therefore, we observed that
PTK1 probably bound to the same region as plumbagin and
possibly followed a similar mechanism for inhibition of KAT
activity. The docking results are consistent with this conclusion
but certainly not conclusive.
Plumbagin Induces p300 Structural Alterations by Inducing
Thiol Cross-links and Adduct Formation—Plumbagin and 1,4-
naphthoquinone share a reactive 3rd position, which could
induce both redox cycling and covalent thiol adduct formation.
Redox cycling in vitro can induce many changes in proteins.
The induction of thiol cross-links between cysteine residues is
one such effect. p300 has three cysteine- and histidine-rich
regions (CH1, CH2, and CH3) and therefore is likely to be
affected by redox states. CH2 and CH3 are adjacent to the KAT
domain. It is possible that redox cycling induces disulfide bonds
in an intermolecular or intramolecular fashion, thereby con-
tributing to KAT inhibition. Full-length p300 is a 300-kilodal-
ton protein (Fig. 10A), and induction of such cross-links can
result in dimerization or oligomerization, which in turn result
in a drastic increase in the protein size. This size increase can be
observed as reducedmobility in SDS-PAGE (without DTT). As
expected, after preincubation with plumbagin analogs (25 or
100 M), there is a variable decrease in mobility (Fig. 10B, lane
1 versus lanes 2–5). The decrease in mobility correlates with
increased protein sequestration at the interface of the stacking
gel and the resolving gel as observed upon Coomassie Blue
staining. This sequestrationwas due to a drastic increase in size,
which was possibly a result of dimer-/oligomerization by thiol
cross-links. Interestingly, PTK1 and juglone induced dimer-/
oligomerization to a lesser extent than plumbagin at both con-
centrations. A reactive 3rd position probably enhances redox
cycling to some extent. As expected, the presence of DTT
greatly reduced the dimer-/oligomerization. It is possible that
dimer-/oligomerization induced by redox cycling of 1,4-naph-
thoquinones contributes to KAT inhibition. PTK1 therefore
possesses a limited ability to induce p300 intra-/intermolecular
thiol cross-links. The thiol-cross-linking abilities of the three
compounds were also compared by a dynamic light scattering
experiment. The results suggest the following features (Fig.
10C). Plumbagin induced oligomerization of p300 to a greater
extent relative to PTK1 and juglone, because the Zav diameter
of untreated p300 (99.9 nm) increased to 161.1 nm in the pres-
FIGURE 7. PTK1 is a noncompetitive inhibitor of p300. A, kinetics of p300 KAT inhibition by PTK1 as represented by a Lineweaver-Burk plot (top left). The
concentration of core histones has been kept constant at 1.7Mwhile increasing the concentration of [3H]acetyl-CoA from 1 to 8M either in the absence (no
inhibitor) or increasing concentrations of PTK1 (15, 20, 25, 35, and 45M). In order to determine the Kiof PTK1 for acetyl-CoA, the slope (Km/Vmax) of the straight
lines obtained from the Lineweaver-Burk plot is plotted against PTK1 concentrations (topmiddle). The apparent Vmax values from the Lineweaver-Burk plot are
plotted against PTK1 concentrations (top right). B, inhibition of p300 KAT activity by PTK1 at a fixed concentration of [3H]acetyl-CoA (1.6 M) and increasing
concentrations of core histones (5–70 nM) either in the absence of (no inhibitor) or increasing concentrations of PTK1 (15, 20, 25, 35, and 45 M). Data are
representedby a Lineweaver-Burk plot (bottom left). In order todetermine theKiof PTK1 for core histone, the slope (Km/Vmax) of the straight lines obtained from
the Lineweaver-Burk plot is plotted against PTK1 concentrations (bottom middle). The apparent Vmax values from the Lineweaver-Burk plot are also plotted
against PTK1 concentrations. (bottom right). Error bars, S.D.
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ence of 25Mplumbagin (Fig. 10C, top). The further addition of
plumbagin (100M) did not cause any significant change in the
Zav diameter of p300. However, in the presence of 25 M PTK1
or juglone, Zav was found to be121 nm. This value increased
to129 nm in the presence of these compounds at 100M.The
Zav diameter trends clearly reflected the differential cross-link-
ing abilities of plumbagin versus PTK1 and juglone (Fig. 10C,
top and bottom). The statistical analysis also supported the
aggregation of p300 in the presence of the three compounds
(data not shown). However, the extent of aggregation follows
the following order: plumbagin 	 PTK1  juglone. These
results further corroborate the findings from the gel electro-
phoresis data.
To understand the structural changes in p300 (KAT3B)
induced by plumbagin and PTK1, we used SERS analysis, which
has been a very effective and quick technique used to look for
gross protein structure. SERS is a unique approach to monitor
structural changes in enzymes such as p300 upon the binding of
FIGURE 8. Reversibility of the inhibition of p300 by plumbagin and PTK1. A, the time-dependent inhibition of p300 by plumbagin. Semilogarithmic
plots showing the time-dependent inactivation of various concentrations of plumbagin (left) and PTK1 (right), as indicated. The results are presented as
the mean  S.D. of triplicate measurements. The residual activity is shown as a percentage of control (without inhibitor) as described under “Experi-
mental Procedures.” The data were fitted against the preincubation time using the semilog line (x is log, y is linear) module of GraphPad Prism version
5.0. The time-dependent inactivation constant, kobs, was obtained from the semilogarithmic plots of the residual activity. B, dialysis was carried out by
incubating p300 with inhibitors for 30 min, and the mixture was dialyzed at 4 °C against 2 HAT assay buffer. The residual activity was assayed and
compared with predialysis activity. The values were mean S.D. of three independent measurements. C, purification profile of recombinant p300 KAT
domain expressed in Escherichia coli. Purified protein was visualized in 12% SDS-polyacrylamide gel and stained with Coomassie Brilliant Blue. D,
time-dependent inhibition of p300 with 25M plumbagin and PTK1 using the p300 KAT domain with compound preincubation times ranging from 1 to
15 min as described earlier.
FIGURE 9.Molecular docking revealed that PTK1 has same binding site as plumbagin. A, docking of PTK1 (shown in a stick representation) onto the p300
KAT domain (shown in a cartoon representation). The crystal structure of the p300 KAT domain was extracted from the Protein Data Bank using the code 3BIY.
B, hydrogenbondingof thePTK1moleculewith the Lys-1358 residue (hydrogenbond length2.51Å, shownas adotted line).C, thedocking conformationof the
PTK1 molecule (carbon, oxygen, and hydrogen atoms are colored in green, red, and white, respectively) and surrounding residues in hydrophobic contact
(carbon, nitrogen, and oxygen atoms are colored in yellow, blue, andwhite, respectively).
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ligands (32–34). These structural changes alter the orientation
of the rings of aromatic amino acids with respect to the nano-
particle surface and thus alter the enhancement of different
ringmodes of these amino acids. In addition, the binding of the
ligand can distance the metal nanoparticle’s surface from that
of the protein, resulting in a reduction in intensity or the disap-
pearance of the associated Raman modes. In cases where
ligands do not bind to the protein, the SERS spectrum of
the protein does not show any changes. SERS is a very sensitive
method, and the spectra of the proteins depend on the distance
and orientation of the protein on the surface of the nanopar-
ticles. Therefore, this technique gives us insight into the struc-
tural changes upon the binding of ligands to proteins (35). The
spectra of baculo-expressed full-length p300 (Fig. 10A) treated
with plumbagin or PTK1 underwent such changes (Fig. 10D).
The tentative SERS band assignments of p300 were performed
as described previously (15, 32, 34, 36). The band at 1619 cm1,
which is the amide I mode, diminished moderately in intensity
in the case of PTK1 and almost completely disappeared in the
case of plumbagin. This result suggested that the binding of the
molecules to the protein took place predominantly in the -he-
lix or -sheet regions. The change in amide I band intensity
directly correlated with the extent of interactions of the com-
pounds with the protein, which resulted in structural changes.
The amide III band occurring at 1295 cm1 also diminished in
intensity, showing binding of the molecules to the secondary
FIGURE 10. p300 undergoes thiol cross-links and adduct formation under redox stress in vitro. A, purification profile of recombinant full-length baculo-
expressed p300. The protein was loaded in 8% SDS-polyacrylamide gel and stained with Coomassie Brilliant Blue stain. B, p300 was incubated with various
1,4-naphthoquinone analogs with 25 M (I) and 100 M (II) for 10 min at 30 °C and subjected to SDS-PAGE without DTT. The gel was stained with Coomassie
BrilliantBlue, including the stacking/resolving interface. Theheavyblackarrow indicatesoligomericp300 in thepresenceofplumbagin (lane2).C, dynamic light
scattering to study the influence of plumbagin, PTK1, and juglone on p300 dimer-/oligomerization. The intensity statistics of 10 measurements each are
plotted for p300 (5M) alone and in the presence of 25Mplumbagin, PTK1, and juglone, respectively (top). The Zav diameters are listed on each panel. Shown
are Zav diameters for p300 (5 M) treated with 25, 50, and 100 M plumbagin, PTK1, and juglone, with error bars indicating S.D. (bottom). The measurements
were performed at 25 °C. D, SERS spectra of p300 alone (black), p300 with PTK1 (blue), and p300 with plumbagin (red).
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structure of the protein. For both PTK1 and plumbagin, there
were changes in the intensities of the bands in the 1150–1550
cm1 region thatwere related to the aromatic amino acids tryp-
tophan, tyrosine, phenylalanine, and histidine, whose orienta-
tions with respect to the nanoparticle surface changed upon
binding of the molecules to the protein. In the case of the p300
protein, we observed the stretching vibrations of C-COO as a
doublet at 910–941 cm1. The presence of this doublet indi-
cated that the protein interacted with the silver nanoparticles
predominantly through the carboxylate groups. However, the
intensity of the doublet decreased in the case of PTK1 and
almost completely disappeared in the case of plumbagin. Plum-
bagin also possesses an intrinsic tendency to bind to free thiol
groups on the surface of the protein through nucleophilic addi-
tion to the C3 carbon. This result was confirmed by the appear-
ance of a peak at 682 cm1, which corresponds to the s(C-S-C)
mode (37). This mode was absent in free protein and protein-
PTK1 spectra. The appearance of this mode specifically when
plumbaginwas applied to p300 gave absolute evidence that pro-
tein-small molecule thiol adducts were being formed. The non-
specific binding of plumbagin to the protein surface could also
prevent nanoparticles from binding to the protein or change
the binding site, thereby causing an overall reduction in inten-
sities of different modes like the C-COO stretching modes.
PTK1Has a Greatly Improved Toxicity Profile—Based on the
observation that 1,4-naphthoquinone derivatives reacted with
NAC at their free 3rd position, we hypothesized that this mode
of reaction between the molecules and various free thiols pres-
ent within the cell could explain their high toxicity. We found
that the application of plumbagin and juglone but not PTK1 at
different concentrations in HeLa S3 and HEK293 cells induced
drastic changes (Fig. 11A). Thus, when there was an excess of
FIGURE 11. PTK1 has a greatly improved toxicity profile. A, HeLa S3 cells were treated with 40 M plumbagin, PTK1, and juglone for 6 h, and microscopic
images were captured (left). HEK293 cells were treated with 50 M plumbagin, PTK1, and juglone for 6 h, and microscopic images were captured (right).
DMSO-treated cellswere used as a control. B, MTT assay to estimate cell viabilitywith 1,4-naphthoquinone analogs either aloneorwithNACpretreatment after
24 h in the SH-SY5Y cell line; C, MTT assay to compare cell viability upon treatment of HeLa S3 cells with 1,4-naphthoquinone analogs and PTK1. The
concentration of the analogs used is indicated in the figure.D, CM-H2DCFDA fluorescent images of HEK293 andHeLa cells obtained after administration of 25
Mplumbagin, juglone, andPTK1 for 2h. Anequal volumeofDMSOwasusedas solvent control. Bright field imageswere taken tomonitor cellularmorphology
after the treatment (left). HeLa cells were administrated with 50M plumbagin (red) and PTK1 (green) for the indicated time period, and DCF fluorescence was
quantified by flow cytometry (right). An equal volume of DMSO (blue) was used as a solvent control. Error bars, S.D.
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free thiols added to the cell culture medium (NAC or DTT),
indiscriminate binding of 1,4-naphthoquinone analogs to cel-
lular thiols and proteins was avoided. Therefore, we performed
anMTTassaywith 1,4-naphthoquinone analogs that reactwith
NAC to score their toxicity in the SH-SY5Y cell line (Fig. 11B).
All of the molecules that bound to free thiols were highly toxic,
resulting in nearly zero viability at 75 M treatment for 24 h.
Excess NAC totally abrogated the analogs’ toxicity even at an
otherwise lethal dose of 75 M, suggesting that reactivity at the
3rd position leads to free thiol reactivity, which caused KAT
inhibition as well as toxicity. Therefore, when we compared
PTK1 with these derivatives, the toxicity was greatly reduced.
Even at 75 M, when other analogs with reactive 3rd positions
caused nearly 100% cell death, PTK1 caused only 20% cell death
upon a 24-h treatment (Fig. 11C). Therefore, among the 1,4-
naphthoquinone KAT inhibitor analogs, PTK1 stood out as
nearly non-toxic. Because the toxicity level of PTK1was greatly
reduced, we examined the ROS generation ability of PTK1.We
found that PTK1 had almost lost the ability to generate ROS,
whereas both plumbagin and juglone generated reactive oxygen
species, as detected by the accumulation of the oxidized fluo-
rescent product DCF inside the cells upon exposure to
CM-H2DCFDA (a cell-permeable, non-fluorescent precursor
of DCF) (Fig. 11D, left). A time course comparison of ROS
induction between plumbagin and PTK1 revealed that PTK1
has a drastically reduced ability to generate ROS (Fig. 11D,
right). As quantified by the accumulation of fluorescence in the
cell, the number of fluorescent cells further decreased over the
monitored time period.
DISCUSSION
Small molecule modulators of lysine acetyltransferases have
recently received enthusiastic attention because they may help
us to understand in vivo KAT function. They also possess tre-
mendous potential as molecules for therapy. Here, we have
described our effort to understand themechanismof action of a
class of KAT inhibitors (naphthoquinones), some of which
interact with thiols in addition to the KATdomain of p300. The
detailed functional analyses of these molecules led to the iden-
tification of the chemical entity responsible for KAT inhibition
and cellular toxicity. Based on this information, we have syn-
thesized a new inhibitor, PTK1,which does not reactwith thiols
and inhibits KATs in a non-competitive and completely revers-
ible fashion. In comparison with other analogs, it exhibits
reduced ROS generation. Therefore, PTK1 is a non-toxic KAT
inhibitor.
Plumbagin is an antiproliferative and cytotoxic compound
(38). We have investigated the mechanism responsible for tox-
icity and have identified that the reactive 3rd position is essen-
tial for toxicity. Furthermore, through its free thiol reactivity,
plumbagin influences p300/CBP KAT inhibition. The contri-
bution of free thiol reactivity to KAT inhibition has also been
suggested for the isothiazone-mediated inhibition of p300/
CBP-associated factor and p300 (39). We previously reported
that the inhibition of KAT activity by plumbagin is may be due
to hydrogen bonding of the single hydroxyl group at the 5th
position to a critical lysine residue within the KAT domain of
p300 (4). This concept has been further strengthened by the
observation that one of the analogs, juglone (5-hydroxy-
2-methyl-1,4 naphthoquinone), which possesses only one
hydroxyl group and does not possess thiol reactivity, greatly
inhibits the KAT activity of p300. Furthermore, our data clearly
suggest that the abilities of plumbagin with regard to redox
cycling and the formation of adducts with the enzyme result in
the toxicity of this molecule.
Based on this structure-function information about plumba-
gin, we synthesized a derivative, PTK1 that, because of a methyl
substitution at the 3rd position, does not react with thiols. PTK1
possesses a hydroxyl group at the 5th position, which probably
maintains its KAT-inhibitory activity. Although PTK1 showed an
IC50 value similar to that of plumbagin in vitro, its inhibition of
H3K9 acetylation in the cell lines was approximately half that of
plumbagin. We propose two possibilities for this differential
efficiency of PTK1 and plumbagin in the cellular system: 1)
cellular permeability is low for PTK1 compared with plumba-
gin; 2) because plumbagin forms an adduct with the enzyme, it
inhibits the enzyme’s activity more strongly than does PTK1.
ROS generated by plumbagin could also induce thiol cross-
links in the enzyme, thus reducing its activity in the cellular
context.
NAC is able to bind to a wide array of molecules, including
18-glycyrrhetinic acid derivatives, and thus prevent apoptosis
(40). Additionally, NAC prevents plumbagin-dependent inhi-
bition of the NF	B pathway in a free thiol-dependent manner
via inhibition of the association between plumbagin and p65, a
key subunit of the NF	B p50/p65 heterodimer complex (25).
NAC and other free thiol-containing reducing agents, but not
the non-free thiol-reducing agents, modify the immunomodu-
latory activity of plumbagin (26). Apoptosis induced by 1,4-
naphthoquinone analogs, such as plumbagin, can be com-
pletely blocked by NAC but not by the non-free thiol-
containing reducing agents (27). From our study, it is clear that
NAC can completely abrogate the toxicity of plumbagin and its
analogs not only by scavenging ROS (25, 26, 39) but also by
reacting with them directly in a cellular system. Collectively,
thiol donors, such as NAC and DTT, render the 1,4-naphtho-
quinones chemically inert.
In conclusion, we have addressed the chemical mechanisms
that could be involved in influencing KAT inhibition by 1,4-
naphthoquinone, and we have delineated thiol reactivity and
redox cycling. Although both of these mechanisms influence
KAT-inhibitory activity, they are probably subsidiary mecha-
nisms. However, these chemical events are the main causes of
cellular toxicity. We therefore synthesized the molecule PTK1,
which has a modification at the 3rd position and chemically
differs from plumbagin. PTK1, having no thiol-reactive prop-
erty, has fewer pleiotropic and toxic effects but still retains the
ability to inhibit KAT. Stability conferred by a methyl substitu-
tion decreases the redox-cycling and thiol-reactive tendencies
of PTK1 comparedwith plumbagin, thus improving the toxicity
profile of PTK1. Therefore, investigations into the role of the
chemical properties of 1,4-naphthoquinone analogs in cellular
toxicity and the inhibition of acetyltransferase p300 have led to
the synthesis of PTK1, a less toxic inhibitor. However, further
modifications of this molecule are essential to improve its
potency in the nanomolar range.
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